092040.KQ
Amicogen, Inc.
KOE · Healthcare · Biotechnology · KR
KRW 908.00
+2.71%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.43x
- Price / sales
- 1.08x
- Price / cash flow
- -83.46x
Enterprise value
- Enterprise value
- KRW 100.7B
- EV / sales
- 2.16x
- EV / EBITDA
- -11.19x
- EV / EBIT
- -7.90x
- Market cap
- KRW 50.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026